Abstract：Objective: To investigate the effects of esketamine on neuronal injury, inflammation and adenosine monophosphate activated protein kinase (AMPK)/nuclear factor-κB (NF-κB) signaling pathway in rats with traumatic brain injury (TBI). Methods: According to the random number table, the rats were divided into sham operation group, model group, esketamine group (50 mg/kg), AMPK inhibitor group (20 mg/kg), and esketamine+AMPK inhibitor group (50 mg/kg+20 mg/kg). TBI rat models were established in groups except the sham operation group, and each group was given corresponding intervention for 7 days. Modified neurological severity score (mNSS) was used to evaluate the neural function of rats; serum levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were detected by enzyme-linked immunosorbent assay; HE staining was used to observe the pathological changes of the brain tissue around the lesion; Nissner staining was used to observe the damage of neurons in the brain surrounding the lesion; TUNEL was used to detect the apoptosis of neurons in the brain surrounding the lesion; detection of AMPK/NF-κB pathway protein expression in the brain tissue around the injured focus of rats by Western blot. Results: Compared with the sham group, rats in the model group showed severe lesions and neuronal damage around the foci of injury. mNSS score, serum IL-6, TNF-α, neuronal apoptosis number, phosphorylated NF-κB p65 (p-NF-κB p65)/NF-κB p65 protein expression were significantly increased, and phosphorylated AMPK (p-AMPK)/AMPK protein expression was significantly decreased (P<0.05). Compared with the model group, the brain tissue pathological condition and neuronal damage around the injury foci were improved in the esketamine group. mNSS score, serum IL-6, TNF-α, neuronal apoptosis number, p-NF-κB p65/NF-κB p65 protein expression was significantly reduced and p-AMPK/AMPK protein expression was significantly increased in the AMPK inhibitor group (P<0.05). In rats, brain tissue lesions and neuronal damage around the injury foci were aggravated, and mNSS score, serum IL-6, TNF-α, neuronal apoptosis number, p-NF-κB p65/NF-κB p65 protein expression were significantly increased and p-AMPK/AMPK protein expression were significantly decreased (P<0.05). The changes in each of these indices in the esketamine + AMPK inhibitor group were between the esketamine and AMPK inhibitor groups. Conclusion: Esketamine can alleviate the neuronal injury and inflammatory reaction in TBI rats, which may be related to the regulation of AMPK/NF-κB pathway.
[1] Xu XJ,Ge QQ,Yang MS,et al.Neutrophil-derived interleukin-17A participates in neuroinflammation induced by traumatic brain injury[J].Neural Regen Res,2023,18(5):1046-1051. [2] Lopez JP,Lucken MD,Brivio E,et al.Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2[J].Neuron,2022,110(14):2283-2298. [3] Lima TM,Visacri MB,Aguiar PM.Use of ketamine and esketamine for depression:an overview of systematic reviews with meta-analyses[J].Eur Clin Pharmacol,2022,78(3):311-338. [4] 齐亚南,潘树义,郭大志.早期不同压力高压氧对中重型颅脑创伤大鼠的神经功能及IL-1β,IL-10和SOD表达的影响[J].转化医学杂志,2020,9(6):321-325. [5] 马登磊,张旭,张丽,等.山茱萸环烯醚萜苷对创伤性脑损伤大鼠认知功能及tau蛋白磷酸化的影响[J].首都医科大学学报,2020,41(3):397-402. [6] 杨欢,吴涛,王瑞辉,等.电针干预对创伤性颅脑损伤大鼠脑组织中p-AMPK、p-mTOR蛋白表达的影响[J].时珍国医国药,2022,33(5):1248-1251. [7] 咸淑悦,熊冰睿,方清,等.艾司氯胺酮对大鼠脓毒症急性肾损伤的影响及自噬在其中的作用[J].中华麻醉学杂志,2021,41(8):1000-1004. [8] Cao B,Zhang Y,Chen J,et al.Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson's disease[J].Metab Brain Dis,2022,37(2):451-462. [9] 张军艳,樊玉香,栗延伟,等.锌离子螯合剂DEDTC对MCAO大鼠的神经功能损害及AMPK/eNOS/NF-κB通路的调节作用[J].卒中与神经疾病,2019,26(6):664-667.
2023, Vol. 29 
冀公网安备13080202000677号